Kenvue has reported robust growth across sales, margins, and earnings in Q1 of 2026, with its Skin Health and Beauty division delivering the strongest performance as the company advances toward its planned acquisition by Kimberly-Clark.

Danone is closing its plant-based beverage facility in Bridgeton, New Jersey, with the site scheduled to cease operations on August 4. The closure will affect 114 employees, with layoffs running through November 2, according to a Worker Adjustment and Retraining Notification (WARN) filed with the state.

One of the most challenging aspects of combatting HIV-1 infection is that the virus continually evades neutralizing antibodies. However, one consequence of this is that a small percentage of people with HIV-1 (1-5%) develop rare, broadly neutralizing antibodies (bNAbs) that can neutralize a large fraction of global HIV-1 isolates. These broadly neutralizing antibodies are among the most promising new long-acting HIV treatments, offering the potential to forego traditional daily dose of antiretroviral drugs. Indeed, a recent trial found that participants who received a single dose of two bNAbs maintained a nearly undetectable viral load for up to 20 weeks, and a third did so for about a year.